Publikationen in Zusammenarbeit mit Forschern von Imperial College London (47)

2024

  1. Plasma fibrinogen and risk of vascular recurrence after ischaemic stroke: An individual participant and summary-level data meta-analysis of 11 prospective studies

    European Stroke Journal

2023

  1. C-Reactive Protein, Interleukin-6, and Vascular Recurrence After Stroke: An Individual Participant Data Meta-Analysis

    Stroke, Vol. 54, Núm. 5, pp. 1289-1299

  2. Erratum: Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores (Nature communications (2021) 12 1 (3417))

    Nature communications

  3. Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis

    JAMA, Vol. 330, Núm. 13, pp. 1266-1277

  4. Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP

    European Journal of Preventive Cardiology, Vol. 30, Núm. 1, pp. 8-16

  5. Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study

    The Lancet Respiratory Medicine, Vol. 11, Núm. 1, pp. 55-64

2022

  1. Impact of Phenol-Enriched Olive Oils on Serum Metabonome and Its Relationship with Cardiometabolic Parameters: A Randomized, Double-Blind, Cross-Over, Controlled Trial

    Antioxidants, Vol. 11, Núm. 10

  2. New insights into the genetic etiology of Alzheimer's disease and related dementias

    Nature genetics, Vol. 54, Núm. 4, pp. 412-436

  3. Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery

    BJS Open, Vol. 6, Núm. 1

2021

  1. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

    Nature communications, Vol. 12, Núm. 1, pp. 3417

  2. Genomic characterization of host factors related to SARS-CoV-2 infection in people with dementia and control populations: The GR@ACE/DEGESCO study

    Journal of Personalized Medicine, Vol. 11, Núm. 12

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Incorporating kidney disease measures into cardiovascular risk prediction: Development and validation in 9 million adults from 72 datasets

    EClinicalMedicine, Vol. 27

2019

  1. Chronic airway diseases Early stratification (CADSET): A new ERS clinical research collaboration

    European Respiratory Journal, Vol. 53, Núm. 3

  2. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

    The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 8, pp. 618-628

  3. Large expert-curated database for benchmarking document similarity detection in biomedical literature search

    Database, Vol. 2019, pp. 1-67

  4. Nrf2 deficiency aggravates Angiotensin II-induced cardiac injury by increasing hypertrophy and enhancing IL-6/STAT3-dependent inflammation

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1865, Núm. 6, pp. 1253-1264

2017

  1. Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer (Nature Genetics (2014) 46 (736-741))

    Nature Genetics

  2. Diagnostic accuracy of the Xpert® MTB/RIF cycle threshold level to predict smear positivity: A meta-analysis

    International Journal of Tuberculosis and Lung Disease, Vol. 21, Núm. 5, pp. 493-502

  3. Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes

    New England Journal of Medicine, Vol. 377, Núm. 13, pp. 1228-1239